Aptevo Therapeutics Files Prospectus Supplement for Up to $2.31 Million ATM Offering

Article summary

Aptevo Therapeutics has filed a prospectus supplement to sell up to $2.31 million of common stock through its existing at-the-market (ATM) offering program.